Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 019071
Company: MISSION PHARMA
Company: MISSION PHARMA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
UROCIT-K | POTASSIUM CITRATE | 5MEQ | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | No |
UROCIT-K | POTASSIUM CITRATE | 10MEQ | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | No |
UROCIT-K | POTASSIUM CITRATE | 15MEQ | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | Yes |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/10/2021 | SUPPL-13 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019071s013lbl.pdf | |
12/10/2021 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019071s013lbl.pdf | |
12/30/2009 | SUPPL-12 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019071s012lbl.pdf | |
12/30/2009 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019071s012lbl.pdf |